Improved meal-related b-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year. - Ahren,B.; Pacini,G.; Foley,J.E.; Schweizer,A. (Diabetes Care, 2005)